[HTML][HTML] Impairment of NK cell function by NKG2D modulation in NOD mice

K Ogasawara, JA Hamerman, H Hsin, S Chikuma… - Immunity, 2003 - cell.com
K Ogasawara, JA Hamerman, H Hsin, S Chikuma, H Bour-Jordan, T Chen, T Pertel
Immunity, 2003cell.com
Nonobese diabetic (NOD) mice, a model of insulin-dependent diabetes mellitus, have a
defect in natural killer (NK) cell-mediated functions. Here we show impairment in an
activating receptor, NKG2D, in NOD NK cells. While resting NK cells from C57BL/6 and NOD
mice expressed equivalent levels of NKG2D, upon activation NOD NK cells but not C57BL/6
NK cells expressed NKG2D ligands, which resulted in downmodulation of the receptor.
NKG2D-dependent cytotoxicity and cytokine production were decreased because of …
Abstract
Nonobese diabetic (NOD) mice, a model of insulin-dependent diabetes mellitus, have a defect in natural killer (NK) cell-mediated functions. Here we show impairment in an activating receptor, NKG2D, in NOD NK cells. While resting NK cells from C57BL/6 and NOD mice expressed equivalent levels of NKG2D, upon activation NOD NK cells but not C57BL/6 NK cells expressed NKG2D ligands, which resulted in downmodulation of the receptor. NKG2D-dependent cytotoxicity and cytokine production were decreased because of receptor modulation, accounting for the dysfunction. Modulation of NKG2D was mostly dependent on the YxxM motif of DAP10, the NKG2D-associated adaptor that activates phosphoinositide 3 kinase. These results suggest that NK cells may be desensitized by exposure to NKG2D ligands.
cell.com